This AFP/c-MYC/miR-29a-centric epigenetic control then plays a factor in increased levels of DNMT3A and DNMT3B which may inhibit tumor suppressor gene expression and drive aggressive HCC and poor outcome [49]. This evidence concerns the gene DNMT3B and hepatocellular carcinoma.